Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Autolus Limited

Clinical trials sponsored by Autolus Limited, explained in plain language.

Autolus Limited AUTL NASDAQ

Clinical-stage biopharmaceutical company developing CAR-T cell therapies.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 4 Not yet finished but already full! 2 Terminated 1

Experimental CAR T-Cell therapy targets tough lymphoma

Disease control Terminated

This early-phase trial tested a new treatment called AUTO4 for people with a type of T-cell lymphoma that had come back or not responded to prior therapy. AUTO4 is a CAR T-cell therapy designed to recognize and attack cancer cells carrying a specific marker called TRBC1. The stud…

Phase: PHASE1, PHASE2 • Sponsor: Autolus Limited • Aim: Disease control

Last updated Jun 27, 2026 11:02 UTC